Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cediranib and Pemetrexed in Relapsed NSCLC
NCT00410904Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Oct 2006
- Primary completion
- Jul 2013
- Countries
- 1
01
Overview
A Phase 2 trial of cediranib in non-small cell lung cancer (NSCLC), sponsored by National Cancer Institute. Started Oct 2006; status: completed.
02
Drugs
cediranib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00410904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00410904.